Choate Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.44M | Sell |
142,810
-1,197
| -0.8% | -$31.3K | 0.06% | 124 |
|
|
2026
Q1 | $4.04M | Sell |
144,007
-2,883
| -2% | -$76.8K | 0.08% | 101 |
|
|
2025
Q4 | $3.66M | Buy |
146,890
+5,166
| +4% | +$130K | 0.07% | 107 |
|
|
2025
Q3 | $3.61M | Buy |
141,724
+1,817
| +1% | +$44.8K | 0.07% | 103 |
|
|
2025
Q2 | $3.39M | Buy |
139,907
+19,722
| +16% | +$460K | 0.07% | 105 |
|
|
2025
Q1 | $3.05M | Sell |
120,185
-19,678
| -14% | -$515K | 0.08% | 107 |
|
|
2024
Q4 | $3.71M | Sell |
139,863
-137
| -0.1% | -$3.72K | 0.09% | 101 |
|
|
2024
Q3 | $4.05M | Sell |
140,000
-4,801
| -3% | -$140K | 0.1% | 94 |
|
|
2024
Q2 | $4.05M | Sell |
144,801
-1,394
| -1% | -$38.4K | 0.11% | 88 |
|
|
2024
Q1 | $4.06M | Sell |
146,195
-15,589
| -10% | -$433K | 0.11% | 98 |
|
|
2023
Q4 | $4.66M | Sell |
161,784
-1,937
| -1% | -$58.6K | 0.14% | 81 |
|
|
2023
Q3 | $5.43M | Buy |
163,721
+22,816
| +16% | +$807K | 0.21% | 51 |
|
|
2023
Q2 | $5.17M | Buy |
140,905
+671
| +0.5% | +$26.1K | 0.22% | 43 |
|
|
2023
Q1 | $5.72M | Buy |
140,234
+71
| +0.1% | +$3.07K | 0.28% | 33 |
|
|
2022
Q4 | $7.18M | Buy |
140,163
+9,709
| +7% | +$465K | 0.43% | 29 |
|
|
2022
Q3 | $5.71M | Buy |
130,454
+2,549
| +2% | +$124K | 0.38% | 30 |
|
|
2022
Q2 | $6.71M | Buy |
127,905
+2,075
| +2% | +$106K | 0.41% | 25 |
|
|
2022
Q1 | $6.51M | Sell |
125,830
-236
| -0.2% | -$12.2K | 0.35% | 25 |
|
|
2021
Q4 | $7.44M | Sell |
126,066
-910
| -0.7% | -$45.1K | 0.43% | 24 |
|
|
2021
Q3 | $5.46M | Sell |
126,976
-2,571
| -2% | -$114K | 0.35% | 25 |
|
|
2021
Q2 | $5.07M | Sell |
129,547
-6,390
| -5% | -$248K | 0.31% | 30 |
|
|
2021
Q1 | $4.92M | Sell |
135,937
-1,880
| -1% | -$66.8K | 0.3% | 32 |
|
|
2020
Q4 | $5.07M | Sell |
137,817
-9,312
| -6% | -$342K | 0.31% | 29 |
|
|
2020
Q3 | $5.12M | Sell |
147,129
-3,328
| -2% | -$117K | 0.33% | 27 |
|
|
2020
Q2 | $4.67M | Sell |
150,457
-7,603
| -5% | -$258K | 0.34% | 30 |
|
|
2020
Q1 | $4.89M | Sell |
158,060
-2,123
| -1% | -$72.3K | 0.39% | 31 |
|
|
2019
Q4 | $5.95M | Sell |
160,183
-2,028
| -1% | -$72.2K | 0.36% | 37 |
|
|
2019
Q3 | $5.53M | Sell |
162,211
-7,508
| -4% | -$273K | 0.34% | 39 |
|
|
2019
Q2 | $6.98M | Sell |
169,719
-2,263
| -1% | -$89.9K | 0.42% | 33 |
|
|
2019
Q1 | $6.93M | Sell |
171,982
-311
| -0.2% | -$12.5K | 0.41% | 31 |
|
|
2018
Q4 | $7.13M | Sell |
172,293
-327
| -0.2% | -$13.6K | 0.46% | 32 |
|
|
2018
Q3 | $7.22M | Sell |
172,620
-20,157
| -10% | -$776K | 0.4% | 28 |
|
|
2018
Q2 | $6.64M | Sell |
192,777
-3,591
| -2% | -$123K | 0.39% | 35 |
|
|
2018
Q1 | $6.61M | Buy |
196,368
+1,110
| +0.6% | +$38.2K | 0.35% | 35 |
|
|
2017
Q4 | $6.71M | Sell |
195,258
-2,688
| -1% | -$91.7K | 0.34% | 34 |
|
|
2017
Q3 | $6.7M | Sell |
197,946
-806
| -0.4% | -$25.9K | 0.36% | 35 |
|
|
2017
Q2 | $6.33M | Sell |
198,752
-2,419
| -1% | -$76.3K | 0.36% | 35 |
|
|
2017
Q1 | $6.53M | Buy |
201,171
+875
| +0.4% | +$27.6K | 0.38% | 35 |
|
|
2016
Q4 | $6.17M | Buy |
200,296
+4,665
| +2% | +$142K | 0.39% | 30 |
|
|
2016
Q3 | $6.29M | Buy |
195,631
+2,003
| +1% | +$67K | 0.41% | 29 |
|
|
2016
Q2 | $6.47M | Sell |
193,628
-6,304
| -3% | -$201K | 0.45% | 30 |
|
|
2016
Q1 | $5.62M | Sell |
199,932
-23,736
| -11% | -$678K | 0.39% | 31 |
|
|
2015
Q4 | $6.61M | Buy |
223,668
+27,867
| +14% | +$877K | 0.48% | 30 |
|
|
2015
Q3 | $5.84M | Buy |
195,801
+16,376
| +9% | +$525K | 0.4% | 27 |
|
|
2015
Q2 | $5.71M | Buy |
179,425
+1,044
| +0.6% | +$34K | 0.33% | 30 |
|
|
2015
Q1 | $5.89M | Sell |
178,381
-45,287
| -20% | -$1.44M | 0.33% | 31 |
|
|
2014
Q4 | $6.61M | Sell |
223,668
-14,432
| -6% | -$414K | 0.39% | 31 |
|
|
2014
Q3 | $6.68M | Sell |
238,100
-254
| -0.1% | -$7.13K | 0.4% | 29 |
|
|
2014
Q2 | $6.71M | Sell |
238,354
-54,880
| -19% | -$1.56M | 0.39% | 30 |
|
|
2014
Q1 | $8.94M | Sell |
293,234
-3,314
| -1% | -$98.8K | 0.55% | 22 |
|
|
2013
Q4 | $8.62M | Sell |
296,548
-15,027
| -5% | -$437K | 0.56% | 24 |
|
|
2013
Q3 | $8.49M | Sell |
311,575
-14,256
| -4% | -$388K | 0.63% | 23 |
|
|
2013
Q2 | $8.66M | Buy |
+325,831
| New | +$9M | 0.69% | 23 |
|
Other funds holding PFE
Choate Investment Advisors's PFE Position: Q2 2026 in Review
Choate Investment Advisors reduced its Pfizer (PFE) stake by 0.83% in Q2 2026, selling an estimated $31.3K and leaving 142,810 shares worth $3.44M. The position accounts for 0.06% of the portfolio, ranked #124.
Choate Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.94M in Q1 2014. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Choate Investment Advisors held 142,810 shares of Pfizer worth $3.44M as of Q2 2026.
- Choate Investment Advisors sold 1,197 Pfizer shares in Q2 2026, an estimated $31.3K.
- Pfizer made up 0.06% of Choate Investment Advisors's portfolio in Q2 2026, its #124 holding.
- Choate Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Choate Investment Advisors's Pfizer position peaked at $8.94M in Q1 2014.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.